76 related articles for article (PubMed ID: 28836557)
1.
Hu N; Wang YH; Li DQ; Yang XH; Tan YL
Chin Med J (Engl); 2017 Sep; 130(17):2117-2118. PubMed ID: 28836557
[No Abstract] [Full Text] [Related]
2. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.
Zheng Z; Chen T; Li X; Haura E; Sharma A; Bepler G
N Engl J Med; 2007 Feb; 356(8):800-8. PubMed ID: 17314339
[TBL] [Abstract][Full Text] [Related]
3. ERCC1 and RRM1: ready for prime time?
Besse B; Olaussen KA; Soria JC
J Clin Oncol; 2013 Mar; 31(8):1050-60. PubMed ID: 23401439
[TBL] [Abstract][Full Text] [Related]
4. [Ribonucleotide reductase and non-small cell lung cancer].
Hsu NY; Lee H; Cheng YW; Yen Y
Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):619-23. PubMed ID: 23092586
[No Abstract] [Full Text] [Related]
5. ERCC1 and non-small-cell lung cancer.
Panasci L; Cohen V
N Engl J Med; 2007 Jun; 356(24):2540; author reply 2540-1. PubMed ID: 17575589
[No Abstract] [Full Text] [Related]
6. ERCC1 and non-small-cell lung cancer.
Zhou SF
N Engl J Med; 2007 Jun; 356(24):2540; author reply 2540-1. PubMed ID: 17575590
[No Abstract] [Full Text] [Related]
7. Gene expression profiles of ERCC1, TYMS, RRM1, TUBB3 and EGFR in tumor tissue from non-small cell lung cancer patients.
Yu D; Li J; Han Y; Liu S; Xiao N; Li Y; Sun X; Liu Z
Chin Med J (Engl); 2014; 127(8):1464-8. PubMed ID: 24762590
[TBL] [Abstract][Full Text] [Related]
8. DNA repair and survival in lung cancer--the two faces of Janus.
Gazdar AF
N Engl J Med; 2007 Feb; 356(8):771-3. PubMed ID: 17314336
[No Abstract] [Full Text] [Related]
9. Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma.
Ren S; Chen X; Kuang P; Zheng L; Su C; Li J; Li B; Wang Y; Liu L; Hu Q; Zhang J; Tang L; Li X; Zhou C; Schmid-Bindert G
Cancer; 2012 Nov; 118(22):5588-94. PubMed ID: 22569898
[TBL] [Abstract][Full Text] [Related]
10. RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC.
Vilmar A; Garcia-Foncillas J; Huarriz M; Santoni-Rugiu E; Sorensen JB
Lung Cancer; 2012 Mar; 75(3):306-12. PubMed ID: 21996087
[TBL] [Abstract][Full Text] [Related]
11. Histology-related associations of ERCC1, RRM1, and TS biomarkers in patients with non-small-cell lung cancer: implications for therapy.
Maus MK; Mack PC; Astrow SH; Stephens CL; Zeger GD; Grimminger PP; Hsiang JH; Huang E; Li T; Lara PN; Danenberg KD; Gandara DR
J Thorac Oncol; 2013 May; 8(5):582-6. PubMed ID: 23470290
[TBL] [Abstract][Full Text] [Related]
12. [Expression and predictive role of excision repair cross complementation group 1, ribonucleotide reductase subunit M1, and β-tubulin 3 in postoperative patients with non-small cell lung cancer receiving adjuvant chemotherapy].
Shi Y; Chen L; Li J; Lü YL; Jiao SC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):375-82. PubMed ID: 20868593
[TBL] [Abstract][Full Text] [Related]
13. [Differential expressions of MDR-1, RRM-1, EGFR and ERCC-1 in primary tumors and metastatic lymph nodes of NSCLC patients].
Guo N; Li S; Zhang W; Yu C; Wang H; Zhang Y; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):870-3. PubMed ID: 23948418
[TBL] [Abstract][Full Text] [Related]
14. [Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)].
Danzinger S; Filipits M
Wien Med Wochenschr; 2007; 157(21-22):554-61. PubMed ID: 18157593
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer.
Pesta M; Kulda V; Fiala O; Safranek J; Topolcan O; Krakorova G; Cerny R; Pesek M
Anticancer Res; 2012 Nov; 32(11):5003-10. PubMed ID: 23155271
[TBL] [Abstract][Full Text] [Related]
16. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
[TBL] [Abstract][Full Text] [Related]
17. Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer.
Volante M; Terzolo M; Fassnacht M; Rapa I; Germano A; Sbiera S; Daffara F; Sperone P; Scagliotti G; Allolio B; Papotti M; Berruti A
Clin Cancer Res; 2012 Jun; 18(12):3452-61. PubMed ID: 22547773
[TBL] [Abstract][Full Text] [Related]
18. Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer.
Rosell R; Manegold C; Moran T; Garrido P; Blanco R; Lianes P; Stahel R; Trigo JM; Wei J; Taron M
Clin Lung Cancer; 2008 Mar; 9 Suppl 2():S76-82. PubMed ID: 21885003
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics: a reality or still a promise?
Bepler G
Lung Cancer; 2006 Dec; 54 Suppl 2(Suppl 2):S3-7. PubMed ID: 17064812
[TBL] [Abstract][Full Text] [Related]
20. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
Bartolucci R; Wei J; Sanchez JJ; Perez-Roca L; Chaib I; Puma F; Farabi R; Mendez P; Roila F; Okamoto T; Taron M; Rosell R
Clin Lung Cancer; 2009 Jan; 10(1):47-52. PubMed ID: 19289372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
